While rhBMP2 treatment was sufficient to phosphorylate PPARγ and induce lipogenic marker expression in primary human IPF lung fibroblasts, rhBMP2 treatment did not result in COL1A1 downregulation. Here, PPARG is linked to idiopathic pulmonary fibrosis.